Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
Semin Radiat Oncol. 2011 Apr;21(2):111-8. doi: 10.1016/j.semradonc.2010.10.002.
Functional and molecular imaging techniques are increasingly being developed and used to quantitatively map the spatial distribution of parameters, such as metabolism, proliferation, hypoxia, perfusion, and ventilation, onto anatomically imaged normal organs and tumor. In radiotherapy optimization, these imaging modalities offer the promise of increased dose sparing to high-functioning subregions of normal organs or dose escalation to selected subregions of the tumor as well as the potential to adapt radiotherapy to functional changes that occur during the course of treatment. The practical use of functional/molecular imaging in radiotherapy optimization must take into cautious consideration several factors whose influences are still not clearly quantified or well understood including patient positioning differences between the planning computed tomography and functional/molecular imaging sessions, image reconstruction parameters and techniques, image registration, target/normal organ functional segmentation, the relationship governing the dose escalation/sparing warranted by the functional/molecular image intensity map, and radiotherapy-induced changes in the image intensity map over the course of treatment. The clinical benefit of functional/molecular image guidance in the form of improved local control or decreased normal organ toxicity has yet to be shown and awaits prospective clinical trials addressing this issue.
功能和分子成像技术正日益得到发展和应用,将代谢、增殖、缺氧、灌注和通气等参数的空间分布定量映射到解剖成像的正常器官和肿瘤上。在放射治疗优化中,这些成像方式有望增加对正常器官高功能亚区的剂量保护,或对肿瘤选定亚区的剂量升级,以及有可能使放射治疗适应治疗过程中发生的功能变化。在放射治疗优化中实际应用功能/分子成像,必须谨慎考虑几个因素,这些因素的影响尚未得到明确量化或很好的理解,包括计划 CT 与功能/分子成像检查之间的患者定位差异、图像重建参数和技术、图像配准、靶区/正常器官功能分割、功能/分子图像强度图所保证的剂量升级/保护的关系,以及治疗过程中图像强度图的放射治疗诱导变化。功能/分子图像引导在提高局部控制或降低正常器官毒性方面的临床获益尚未得到证实,有待前瞻性临床试验来解决这一问题。